Riskpilot← Back to searchSign inGet full accessOstosis AB
ABActiveOrg 5566526660Tunavägen 23Other human health activities n.e.c. · NACE 8699Est. 20030 employees
Revenue 2025
SEK 1,2M
+21% vs 2024
EBITDA margin
40.4%
-17% vs 2024
Equity ratio
78.0%
Financial strength
Net profit 2025
SEK 412K
-9% vs 2024
| Revenue | SEK 1,2M | +21% |
| EBITDA | SEK 491K | -17% |
| Net profit | SEK 412K | -9% |
| Total assets | SEK 8,5M | +2% |
| Equity | SEK 6,6M | +3% |
| Employees | 0 | — |
Legal name
Ostosis AB
Org number
5566526660
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
11 december 2003
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
FIRMAN TECKNAS AV STYRELSEN FIRMAN TECKNAS VAR FÖR SIG AV LEDAMOTEN SUPPLEANTEN
Company purpose
Bolaget skall bedriva medicinsk konsultverksamhet, friskvård, utbildnings-, föreläsnings- samt översättningstjänster inom medicinområdet, handel med värdepapper, handel och uthyrning av fastigheter samt därmed förenlig verksamhet.
Address
Tunavägen 23
Phone
+46733361628
Email
elif.bosemark@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1 632 | 1 655 | 1 488 | 1 193 | 1 190 | 755 | 1 005 | 1 216 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 552 | 1 202 | 1 222 | 1 171 | 1 123 | 1 019 | 803 | 252 | 590 | 491 |
| Depreciation & amort. | −6 | −6 | −0 | −5 | −5 | −5 | −5 | −32 | −120 | −120 |
| EBIT | 1 546 | 1 196 | 1 222 | 1 166 | 1 118 | 1 014 | 798 | 220 | 470 | 371 |
| Net financials | 8 | −5 | −12 | −5 | 215 | −4 | −466 | 236 | 52 | 61 |
| Profit before tax | 1 278 | 1 041 | 985 | 961 | 1 049 | 930 | 660 | 616 | 595 | 533 |
| Tax | −286 | −245 | −230 | −260 | −206 | −204 | −197 | −96 | −143 | −121 |
| Net profit | 992 | 796 | 755 | 701 | 843 | 726 | 463 | 520 | 452 | 412 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 167 | 5 123 | 5 425 | 6 253 | 7 166 | 8 027 | 7 719 | 7 790 | 8 315 | 8 457 |
| Equity | 2 537 | 3 174 | 3 768 | 4 294 | 4 965 | 5 514 | 5 796 | 6 136 | 6 388 | 6 600 |
| Long-term debt | 74 | 321 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 666 | 588 | 392 | 495 | 451 | 683 | 188 | 78 | 424 | 455 |
| Total debt | 740 | 909 | 392 | 495 | 451 | 683 | 188 | 78 | 424 | 455 |
EBITDA margin
40.4%
This company
15.8%
Market median
+156% vs market
20162025
Equity ratio
78.0%
This company
38.2%
Market median
+104% vs market
20162025
Return on equity
6.2%
This company
18.4%
Market median
-66% vs market
20162025
Net profit margin
33.9%
This company
8.1%
Market median
+319% vs market
20162025
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20162025
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ostosis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Kenneth Nilsson | Audit | 0 companies |
| Elif Bosemark | Deputy Board Member | 0 companies |
| Per Olof Bosemark | Board of Directors | 0 companies |